secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2026-07-20T21:20:17+00:00
Accession:  0001493152-26-033942
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspire Biopharma clarifies warrant terms after two reverse splits; exercise price now $13,800
--------------------------------------------------------------------------------

- Original exercise price of $11.50 per share adjusted to $13,800 after 1-for-30 and 40-1 reverse splits.
- Warrant ratio changed to 1,200 warrants to purchase one share of common stock.
- Reverse splits effective January 16, 2026 and May 11, 2026.
- Clarification provided in response to requests from public warrant holders.
- Warrants trade under symbol ASBPW on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226033942/0001493152-26-033942-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226033942/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-033942

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer